Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Zoptarelin doxorubicin - COSCIENS Biopharma

Next Previous
X
Search
Drug Profile

Zoptarelin doxorubicin - COSCIENS Biopharma

Alternative Names: AEZS-108; AN-152; D-81858; Doxorubicin-GnRH agonist conjugate; ZEN-008; Zoptarelin doxorubicin acetate; Zoptrex

Latest Information Update: 08 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tulane University
  • Developer AEterna Zentaris Inc; National Cancer Institute (USA); University of Southern California
  • Class Amines; Anthracyclines; Cytostatic antibiotics; Doxorubicins; Drug conjugates; Naphthacenes; Pyrans
  • Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ovarian cancer
  • New Molecular Entity No
  • Available For Licensing Yes - Endometrial cancer

Highest Development Phases

  • Discontinued Endometrial cancer; Ovarian cancer; Prostate cancer; Triple negative breast cancer; Urogenital cancer

Most Recent Events

  • 06 Aug 2024 AEterna Zentaris Inc is now called COSCIENS Biopharma
  • 13 Jul 2021 Ventana Medical Systems is now called Roche Tissue Diagnostics
  • 08 May 2017 Discontinued - Phase-I/II for Prostate cancer (Hormone refractory, Metastatic disease, Second-line therapy or greater) in USA (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top